Rize Oncology Inc.
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.49% | -8.14% | 41.89% | 7.71% | -50.94% |
| Total Depreciation and Amortization | -- | -85.25% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 101.11% | -80.73% | 1,234.29% | -80.11% | -3.83% |
| Change in Net Operating Assets | 284.43% | 7.66% | -251.43% | 9,871.43% | 100.62% |
| Cash from Operations | 82.48% | -2,056.49% | 95.58% | 22.47% | -6.36% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -590.91% | 214.29% | -93.69% | -73.88% | 2,600.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | 100.00% | -- | -- |
| Net Change in Cash | 99.39% | -244.09% | 163.08% | 9.29% | 5.92% |